Johnson & Johnson vs Insulet Corporation — Stock Comparison

JNJ
Johnson & Johnson
$227.19
▼ 1.16%
vs
PODD
Insulet Corporation
$175.04
▲ 1.68%
Q·Score Winner
Insulet Corporation
PODD7.8/10vs 7.1/10

Q·Score Breakdown

7.1
Bullish
Overall
7.8
Bullish
9.3
Quality
6.4
6.5
Health
7.9
5.1
Growth
8
7.3
Valuation
9.1
6.5
Sentiment
8.1
JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

PODD

Consensus analyst target of $326.35 is 86% above current price.

Analyst Consensus

BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $326.35 (+86.4%)
23 analysts

Fundamentals

JNJ
PODD
26.3×
Trailing P/E
50.3×
17.9×
Forward P/E
21.7×
21.8%
Profit Margin
9.1%
68.0%
Gross Margin
71.6%
26.4%
ROE
18.1%
9.9%
Revenue Growth
31.2%
-52.9%
Earnings Growth
3.9%
0.33
Beta
1.47
Price / Book
$546.9B
Market Cap
$12.1B
$146 – $252
52-Week Range
$158 – $355

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →